{"id":"https://openalex.org/W2498442005","doi":"https://doi.org/10.1158/1538-7445.am2016-4362","title":"Abstract 4362: T cell repertoire diversification is associated with immune related toxicities following immune checkpoint inhibition in metastatic cancer patients","display_name":"Abstract 4362: T cell repertoire diversification is associated with immune related toxicities following immune checkpoint inhibition in metastatic cancer patients","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2498442005","doi":"https://doi.org/10.1158/1538-7445.am2016-4362","mag":"2498442005"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-4362","doi":"https://doi.org/10.1158/1538-7445.am2016-4362","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-4362","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058893054","display_name":"David Yoonsuk Oh","orcid":"https://orcid.org/0000-0002-3310-0994","observed_orcids":["https://orcid.org/0000-0002-3310-0994"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Y. Oh","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089694286","display_name":"Jason Cham","orcid":"https://orcid.org/0000-0002-4748-3930","observed_orcids":["https://orcid.org/0000-0002-4748-3930"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Cham","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620","https://orcid.org/0009-0001-8129-4308"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008519742","display_name":"Grant Fong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grant Fong","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022565348","display_name":"Mark Klinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Klinger","raw_affiliation_strings":["2Adaptive Biotechnologies, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Adaptive Biotechnologies, South San Francisco, CA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111574602","display_name":"Malek Faham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malek Faham","raw_affiliation_strings":["2Adaptive Biotechnologies, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Adaptive Biotechnologies, South San Francisco, CA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Fong","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"4362","last_page":"4362"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8199999928474426},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9729999899864197},{"id":"https://openalex.org/keywords/t-cell-repertoire-diversity","display_name":"T cell repertoire diversity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/t-cell-clonotypes","display_name":"T cell clonotypes","score":0.9039999842643738},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.925000011920929},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade-response","display_name":"immune checkpoint blockade response","score":0.5799999833106995},{"id":"https://openalex.org/keywords/toxicity-biomarkers","display_name":"biomarkers of toxicity","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7295870780944824},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6492437720298767},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5518518090248108},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.539063572883606},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5071320533752441},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.486073762178421},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.48509252071380615},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47532370686531067},{"id":"https://openalex.org/C2778473898","wikidata":"https://www.wikidata.org/wiki/Q2145110","display_name":"Repertoire","level":2,"score":0.46629565954208374},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38599449396133423},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3248628079891205},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.26583579182624817},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06292364001274109},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-4362","doi":"https://doi.org/10.1158/1538-7445.am2016-4362","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-4362","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2889777167","https://openalex.org/W2566809924","https://openalex.org/W3137229530","https://openalex.org/W4206697524","https://openalex.org/W4388531148","https://openalex.org/W4385264187","https://openalex.org/W2603417663","https://openalex.org/W4388068608","https://openalex.org/W2948198910","https://openalex.org/W3203062316"],"abstract_inverted_index":{"Abstract":[0],"Immune":[1],"checkpoint":[2,80,228,245,287],"inhibitors":[3,81],"can":[4,84,247],"induce":[5],"clinical":[6,128,225],"responses":[7,20],"to":[8,37,86,126,227,253],"a":[9,112,142,197],"broad":[10],"range":[11],"of":[12,103,111,132,155,162,168,181,200,221,296,301],"tumor":[13],"types":[14],"by":[15,49],"presumably":[16],"enhancing":[17],"T":[18,87,114,145,156,171,193,208,275],"cell":[19,88,115,146,157,172,276],"against":[21],"the":[22,101,109,130,153,160,169,179,218,297,302],"tumor.":[23],"These":[24,236],"treatments":[25],"are":[26,34,60,138],"also":[27,35,231],"associated":[28,99,140,232,280],"with":[29,79,100,141,149,176,233,255,281],"certain":[30],"side":[31],"effects":[32],"that":[33,55,74,94,136,239],"thought":[36],"be":[38,248],"immune":[39,240,244,282,286],"mediated":[40],"(termed":[41],"immune-related":[42],"adverse":[43],"events,":[44],"or":[45],"IRAEs).":[46],"The":[47],"mechanism":[48,220],"which":[50,212],"IRAEs":[51,137],"occur,":[52],"and":[53,148,251],"biomarkers":[54],"may":[56,213],"predict":[57],"IRAE":[58,184,222],"development,":[59],"unknown.":[61],"In":[62],"prior":[63],"work":[64],"(Cha":[65],"et":[66],"al.":[67],"Sci":[68],"Transl":[69],"Med":[70],"2014),":[71],"we":[72,92,118],"demonstrated":[73],"treating":[75],"metastatic":[76,256,290],"cancer":[77,291],"patients":[78,185,254],"blocking":[82],"CTLA-4":[83],"lead":[85],"repertoire":[89,147,173,241,277],"diversification.":[90],"However,":[91],"found":[93],"prolonged":[95],"survival":[96],"was":[97],"not":[98],"induction":[102],"high":[104],"frequency":[105],"clonotypes,":[106,158],"but":[107],"rather":[108],"maintenance":[110],"pre-existing":[113],"response.":[116],"Here,":[117],"examined":[119],"whether":[120],"treatment-induced":[121],"TCR":[122],"diversification":[123,278],"is":[124,230,279],"related":[125,283],"another":[127],"outcome:":[129],"development":[131,180],"IRAEs.":[133,182],"We":[134],"find":[135],"specifically":[139],"more":[143],"diverse":[144],"an":[150],"increase":[151],"in":[152,190,202,205,217,289],"number":[154],"including":[159],"generation":[161],"de":[163],"novo":[164],"clones.":[165],"This":[166],"broadening":[167],"circulating":[170],"occurred":[174],"early":[175],"treatment,":[177],"preceding":[178],"While":[183],"demonstrate":[186,196],"markedly":[187],"greater":[188,198],"diversity":[189,242],"their":[191,206],"CD4+":[192],"cells,":[194],"they":[195],"degree":[199],"change":[201],"clonal":[203],"frequencies":[204],"CD8+":[207],"cells":[209],"after":[210],"ipilimumab,":[211],"have":[214],"key":[215],"implications":[216],"pathogenic":[219],"development.":[223],"Finally,":[224],"response":[226],"blockade":[229],"increased":[234],"diversity.":[235],"results":[237],"indicate":[238],"following":[243,285],"inhibition":[246,288],"both":[249],"detrimental":[250],"beneficial":[252],"cancer.":[257],"Citation":[258],"Format:":[259],"David":[260],"Y.":[261],"Oh,":[262],"Jason":[263],"Cham,":[264],"Li":[265],"Zhang,":[266],"Grant":[267],"Fong,":[268],"Mark":[269],"Klinger,":[270],"Malek":[271],"Faham,":[272],"Lawrence":[273],"Fong.":[274],"toxicities":[284],"patients.":[292],"[abstract].":[293],"In:":[294],"Proceedings":[295],"107th":[298],"Annual":[299],"Meeting":[300],"American":[303],"Association":[304],"for":[305],"Cancer":[306,317],"Research;":[307],"2016":[308],"Apr":[309],"16-20;":[310],"New":[311],"Orleans,":[312],"LA.":[313],"Philadelphia":[314],"(PA):":[315],"AACR;":[316],"Res":[318],"2016;76(14":[319],"Suppl):Abstract":[320],"nr":[321],"4362.":[322]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2016-08-23T00:00:00"}